Literature DB >> 25093878

Rethinking clinical delivery of adult stem cell therapies.

Nuala Trainor1, Alexis Pietak1, Tim Smith1.   

Abstract

Mesh：

Year:  2014        PMID： 25093878     DOI： 10.1038/nbt.2970

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  10 in total

Review 1.  Allogeneic immunotherapy to optimize the graft-versus-tumor effect: concepts and controversies.

Authors:  David L Porter
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2011

2.  FDA regulation of stem-cell-based therapies.

Authors:  Dina Gould Halme; David A Kessler
Journal:  N Engl J Med       Date:  2006-10-19       Impact factor: 91.245

3.  Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair.

Authors:  Xi-Ping Huang; Zhuo Sun; Yasuo Miyagi; Heather McDonald Kinkaid; Li Zhang; Richard D Weisel; Ren-Ke Li
Journal:  Circulation       Date:  2010-11-22       Impact factor: 29.690

4.  Bioreactor-based roadmap for the translation of tissue engineering strategies into clinical products.

Authors:  Ivan Martin; Timothy Smith; David Wendt
Journal:  Trends Biotechnol       Date:  2009-08-03       Impact factor: 19.536

5.  Regenerative medicine.

Authors:  Jason P Glotzbach; Victor W Wong; Geoffrey C Gurtner; Michael T Longaker
Journal:  Curr Probl Surg       Date:  2011-03       Impact factor: 1.909

6.  Ownership and use of tissue specimens for research.

Authors:  Rina Hakimian; David Korn
Journal:  JAMA       Date:  2004-11-24       Impact factor: 56.272

7.  Bioreactor based engineering of large-scale human cartilage grafts for joint resurfacing.

Authors:  Rosaria Santoro; Andy L Olivares; Gerben Brans; Dieter Wirz; Cristina Longinotti; Damien Lacroix; Ivan Martin; David Wendt
Journal:  Biomaterials       Date:  2010-08-25       Impact factor: 12.479

Review 8.  Human mesenchymal stem cells: from basic biology to clinical applications.

Authors:  B M Abdallah; M Kassem
Journal:  Gene Ther       Date:  2007-11-08       Impact factor: 5.250

Review 9.  Concise review: immunomodulatory properties of mesenchymal stem cells in cellular transplantation: update, controversies, and unknowns.

Authors:  Rony Atoui; Ray C J Chiu
Journal:  Stem Cells Transl Med       Date:  2012-03-12       Impact factor: 6.940

10.  Does the FDA have regulatory authority over adult autologous stem cell therapies? 21 CFR 1271 and the emperor's new clothes.

Authors:  Michael Freeman; Mitchell Fuerst
Journal:  J Transl Med       Date:  2012-03-26       Impact factor: 5.531
  10 in total
  14 in total

Review 1.  Bone marrow mesenchymal stem cell therapy for voiding dysfunction.

Authors:  Alice Yu; Lysanne Campeau
Journal:  Curr Urol Rep       Date:  2015-07       Impact factor: 3.092

2.  Soluble matrix protein is a potent modulator of mesenchymal stem cell performance.

Authors:  Giselle C Yeo; Anthony S Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-18       Impact factor: 11.205

3.  Osteogenic ability of rat bone marrow concentrate is at least as efficacious as mesenchymal stem cells in vitro.

Authors:  Yusuke Kohno; Tzuhua Lin; Jukka Pajarinen; Monica Romero-Lopez; Masahiro Maruyama; Jhih-Fong Huang; Karthik Nathan; Zhenyu Yao; Stuart B Goodman
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2019-02-19       Impact factor: 3.368

Review 4.  Biomanufacturing for clinically advanced cell therapies.

Authors:  Ayesha Aijaz; Matthew Li; David Smith; Danika Khong; Courtney LeBlon; Owen S Fenton; Ronke M Olabisi; Steven Libutti; Jay Tischfield; Marcela V Maus; Robert Deans; Rita N Barcia; Daniel G Anderson; Jerome Ritz; Robert Preti; Biju Parekkadan
Journal:  Nat Biomed Eng       Date:  2018-06-11       Impact factor: 25.671

5.  Sugar-Assisted Cryopreservation of Stem Cell-Laden Gellan Gum-Collagen Interpenetrating Network Hydrogels.

Authors:  Jian Yao Ng; Kee Ying Fremi Tan; Pui Lai Rachel Ee
Journal:  Biomacromolecules       Date:  2022-06-08       Impact factor: 6.978

Review 6.  Immune Reactivation by Cell-Free Fetal DNA in Healthy Pregnancies Re-Purposed to Target Tumors: Novel Checkpoint Inhibition in Cancer Therapeutics.

Authors:  Elizabeth Ann L Enninga; Wendy K Nevala; Shernan G Holtan; Svetomir N Markovic
Journal:  Front Immunol       Date:  2015-08-26       Impact factor: 7.561

Review 7.  Mesenchymal stem cell-based therapy in kidney transplantation.

Authors:  Cheng Chen; Jianquan Hou
Journal:  Stem Cell Res Ther       Date:  2016-02-07       Impact factor: 6.832

8.  An Integrated Miniature Bioprocessing for Personalized Human Induced Pluripotent Stem Cell Expansion and Differentiation into Neural Stem Cells.

Authors:  Haishuang Lin; Qiang Li; Yuguo Lei
Journal:  Sci Rep       Date:  2017-01-06       Impact factor: 4.379

9.  Probing the mechanism for hydrogel-based stasis induction in human pluripotent stem cells: is the chemical functionality of the hydrogel important?

Authors:  M Sponchioni; C T O'Brien; C Borchers; E Wang; M N Rivolta; N J W Penfold; I Canton; S P Armes
Journal:  Chem Sci       Date:  2019-11-11       Impact factor: 9.825

10.  Characterization of a Self-renewing and Multi-potent Cell Population Isolated from Human Minor Salivary Glands.

Authors:  Lin Lu; Yan Li; Ming-juan Du; Chen Zhang; Xiang-yu Zhang; Hai-zhou Tong; Lei Liu; Ting-lu Han; Wan-di Li; Li Yan; Ning-bei Yin; Hai-dong Li; Zhen-min Zhao
Journal:  Sci Rep       Date:  2015-06-09       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.